5 Biotech Stocks to Buy According to Billionaire David E. Shaw

Page 5 of 5

1. Moderna, Inc. (NASDAQ:MRNA)

D.E. Shaw’s Stake Value: $257 million

Percentage of D.E. Shaw’s 13F Portfolio: 0.21%

Number of Hedge Fund Holders: 45

Moderna, Inc. (NASDAQ:MRNA) is a biotechnology firm that uses messenger ribonucleic acid (mRNA) for developing treatments for several diseases. These include infectious diseases, various cancers, cardiovascular diseases, and other maladies. The company rose to mainstream prominence thanks to its vaccine for the coronavirus pandemic, which is rated among the best in the world.

Moderna, Inc. (NASDAQ:MRNA)’s fiscal Q4 results saw it beat analysts’ revenue and GAAP EPS estimates, as the company posted $7.2 billion in revenue and $11.29 in GAAP EPS respectively. At the same time, the company announced a $3 billion share buyback as an incentive to investors who were worried about its share price.

Dr. Shaw’s D.E. Shaw had amassed a $257 million stake in Moderna, Inc. (NASDAQ:MRNA) by the end of Q4 2021, holding 1.01 million shares of the drug company. 45 hedge funds tracked by Insider Monkey’s database owned the company’s shares on December 31. Moderna, Inc. (NASDAQ:MRNA)’s largest investor among that group was Patrick Degorce’s Theleme Partners, which owned 5.02 million shares worth $1.28 billion.

Disclosure: None. You can also take a look at 12 Best Environmental Stocks to Invest In and 10 Best Nickel Stocks to Buy Now.

Page 5 of 5